Glucose-6-phosphate dehydrogenase deficiency risk factors: Difference between revisions
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4]. | ||
===Common Risk | ===Common Risk Factor=== | ||
*Common risk factors in the development of G6PD include: | *Common risk factors in the development of G6PD include: | ||
**Foods such as fava beans in G6PD mutation carriers | **Foods such as fava beans in G6PD mutation carriers | ||
**Medications such as: | **Medications such as: | ||
***Aspirin | ***Aspirin | ||
***Antimalarials: quinine, primaquine, pamaquine, and chloroquine | ***Antimalarials: quinine, primaquine, pamaquine, and chloroquine | ||
***Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole | ***Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole | ||
***Thiazolesulfone | ***Thiazolesulfone | ||
***Methylene blue | ***Methylene blue | ||
***Analgesics: phenazopyridine and acetanilide | ***Analgesics: phenazopyridine and acetanilide | ||
***Rasburicase | ***Rasburicase | ||
| Line 48: | Line 47: | ||
** | ** | ||
**Diabetic ketoacidosis<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref> | **Diabetic ketoacidosis<ref name="pmid4623682">{{cite journal |vauthors=Gellady AM, Greenwood RD |title=G-6-PD hemolytic anemia complicating diabetic ketoacidosis |journal=J. Pediatr. |volume=80 |issue=6 |pages=1037–8 |date=June 1972 |pmid=4623682 |doi= |url=}}</ref> | ||
**Amyl nitrite or isobutyl nitrite in RUSH ( sexual enhancement drug)<ref name="pmid8081534">{{cite journal |vauthors=Beaupre SR, Schiffman FJ |title=Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use |journal=Arch Fam Med |volume=3 |issue=6 |pages=545–8 |date=June 1994 |pmid=8081534 |doi= |url=}}</ref> | |||
** | |||
==References== | ==References== | ||
Revision as of 16:45, 14 August 2018
|
Glucose-6-phosphate dehydrogenase deficiency Microchapters |
|
Differentiating Glucose-6-phosphate dehydrogenase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Glucose-6-phosphate dehydrogenase deficiency risk factors On the Web |
|
American Roentgen Ray Society Images of Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
FDA on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
CDC on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
Glucose-6-phosphate dehydrogenase deficiency risk factors in the news |
|
Blogs on Glucose-6-phosphate dehydrogenase deficiency risk factors |
|
Directions to Hospitals Treating Glucose-6-phosphate dehydrogenase deficiency |
|
Risk calculators and risk factors for Glucose-6-phosphate dehydrogenase deficiency risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mahda Alihashemi M.D. [2]
Overview
There are no established risk factors for [disease name].
OR
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.
Risk Factors
The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
OR
Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
Common Risk Factor
- Common risk factors in the development of G6PD include:
- Foods such as fava beans in G6PD mutation carriers
- Medications such as:
- Aspirin
- Antimalarials: quinine, primaquine, pamaquine, and chloroquine
- Sulfonamides: mafenide, sulfanilamide, sulfamethoxazole
- Thiazolesulfone
- Methylene blue
- Analgesics: phenazopyridine and acetanilide
- Rasburicase
- Some non-sulfa antibiotics : furazolidone, isoniazid, dapsone, nalidixic acid, nitrofurantoin). Henna has been known to cause hemolytic crisis in G6PD-deficient infants. Rasburicase is also contraindicated in G6PD deficiency. High dose intravenous vitamin C has also been known to cause haemolysis in G6PD deficiency carriers, thus G6PD deficiency testing is routine before infusion of doses of 25g or more.
- Bacterial, viral and rickettsial infection
- Some chemicals: Hanna in tattos and hair dyes.[1]
Less Common Risk Factors
- Less common risk factors in the development of G6PD include:
References
- ↑ Raupp P, Hassan JA, Varughese M, Kristiansson B (November 2001). "Henna causes life threatening haemolysis in glucose-6-phosphate dehydrogenase deficiency". Arch. Dis. Child. 85 (5): 411–2. PMC 1718961. PMID 11668106.
- ↑ Gellady AM, Greenwood RD (June 1972). "G-6-PD hemolytic anemia complicating diabetic ketoacidosis". J. Pediatr. 80 (6): 1037–8. PMID 4623682.
- ↑ Beaupre SR, Schiffman FJ (June 1994). "Rush hemolysis. A 'bite-cell' hemolytic anemia associated with volatile liquid nitrite use". Arch Fam Med. 3 (6): 545–8. PMID 8081534.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [3]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [4]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Risk Factors
- Ethnic groups
- African American
- Middle Eastern decent, particularly Kurdish or Sephardic Jewish
- Male
- Family history of the deficiency